Michael Mano, SVP, General Counsel&Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 2,793 shares at $6.29 ($18K) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Seasonal sale ($18k) by SVP, General Counsel&Secretary — this insider has traded KPTI in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2025-09-16 | $2K | — | Filing → |
| KPTI | SELL | 2024-09-05 | $3K | — | Filing → |
| KPTI | SELL | 2024-03-04 | $24K | — | Filing → |